These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 25812842)

  • 1. Deaths averted by influenza vaccination in the U.S. during the seasons 2005/06 through 2013/14.
    Foppa IM; Cheng PY; Reynolds SB; Shay DK; Carias C; Bresee JS; Kim IK; Gambhir M; Fry AM
    Vaccine; 2015 Jun; 33(26):3003-9. PubMed ID: 25812842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Burden of medically attended influenza infection and cases averted by vaccination - United States, 2013/14 through 2015/16 influenza seasons.
    Jackson ML; Phillips CH; Benoit J; Jackson LA; Gaglani M; Murthy K; McLean HQ; Belongia EA; Malosh R; Zimmerman R; Flannery B
    Vaccine; 2018 Jan; 36(4):467-472. PubMed ID: 29249545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Net Costs Due to Seasonal Influenza Vaccination--United States, 2005-2009.
    Carias C; Reed C; Kim IK; Foppa IM; Biggerstaff M; Meltzer MI; Finelli L; Swerdlow DL
    PLoS One; 2015; 10(7):e0132922. PubMed ID: 26230271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An evaluation and update of methods for estimating the number of influenza cases averted by vaccination in the United States.
    Tokars JI; Rolfes MA; Foppa IM; Reed C
    Vaccine; 2018 Nov; 36(48):7331-7337. PubMed ID: 30327213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimating the Effect of a National Pharmacy-Led Influenza Vaccination Voucher Program on Morbidity, Mortality, and Costs.
    Singh T; Taitel M; Loy D; Smith-Ray R
    J Manag Care Spec Pharm; 2020 Jan; 26(1):42-47. PubMed ID: 31880234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimating Direct and Indirect Protective Effect of Influenza Vaccination in the United States.
    Arinaminpathy N; Kim IK; Gargiullo P; Haber M; Foppa IM; Gambhir M; Bresee J
    Am J Epidemiol; 2017 Jul; 186(1):92-100. PubMed ID: 28369163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surveillance of influenza vaccination coverage--United States, 2007-08 through 2011-12 influenza seasons.
    Lu PJ; Santibanez TA; Williams WW; Zhang J; Ding H; Bryan L; O'Halloran A; Greby SM; Bridges CB; Graitcer SB; Kennedy ED; Lindley MC; Ahluwalia IB; LaVail K; Pabst LJ; Harris L; Vogt T; Town M; Singleton JA;
    MMWR Surveill Summ; 2013 Oct; 62(4):1-28. PubMed ID: 24157710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimated influenza illnesses and hospitalizations averted by influenza vaccination - United States, 2012-13 influenza season.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2013 Dec; 62(49):997-1000. PubMed ID: 24336131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimated influenza illnesses and hospitalizations averted by vaccination--United States, 2013-14 influenza season.
    Reed C; Kim IK; Singleton JA; Chaves SS; Flannery B; Finelli L; Fry A; Burns E; Gargiullo P; Jernigan D; Cox N; Bresee J;
    MMWR Morb Mortal Wkly Rep; 2014 Dec; 63(49):1151-4. PubMed ID: 25503917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influenza Illness and Hospitalizations Averted by Influenza Vaccination in the United States, 2005-2011.
    Kostova D; Reed C; Finelli L; Cheng PY; Gargiullo PM; Shay DK; Singleton JA; Meltzer MI; Lu PJ; Bresee JS
    PLoS One; 2013; 8(6):e66312. PubMed ID: 23840439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimated influenza illnesses and hospitalizations averted by influenza vaccination among children aged 6-59 months in Suzhou, China, 2011/12 to 2015/16 influenza seasons.
    Zhang W; Gao J; Chen L; Tian J; Biggerstaff M; Zhou S; Situ S; Wang Y; Zhang J; Millman AJ; Greene CM; Zhang T; Zhao G
    Vaccine; 2020 Dec; 38(51):8200-8205. PubMed ID: 33176936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early estimates of seasonal influenza vaccine effectiveness - United States, January 2015.
    Flannery B; Clippard J; Zimmerman RK; Nowalk MP; Jackson ML; Jackson LA; Monto AS; Petrie JG; McLean HQ; Belongia EA; Gaglani M; Berman L; Foust A; Sessions W; Thaker SN; Spencer S; Fry AM;
    MMWR Morb Mortal Wkly Rep; 2015 Jan; 64(1):10-5. PubMed ID: 25590680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of influenza vaccination on infection, hospitalisation and mortality in the Netherlands between 2003 and 2015.
    Backer JA; Wallinga J; Meijer A; Donker GA; van der Hoek W; van Boven M
    Epidemics; 2019 Mar; 26():77-85. PubMed ID: 30344024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of national influenza vaccination strategy in severe influenza outcomes among the high-risk Portuguese population.
    Machado A; Kislaya I; Larrauri A; Matias Dias C; Nunes B
    BMC Public Health; 2019 Dec; 19(1):1690. PubMed ID: 31842831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigating the impact of influenza on excess mortality in all ages in Italy during recent seasons (2013/14-2016/17 seasons).
    Rosano A; Bella A; Gesualdo F; Acampora A; Pezzotti P; Marchetti S; Ricciardi W; Rizzo C
    Int J Infect Dis; 2019 Nov; 88():127-134. PubMed ID: 31401203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of influenza vaccination programmes among the elderly population on primary care, Portugal, Spain and the Netherlands: 2015/16 to 2017/18 influenza seasons.
    Machado A; Mazagatos C; Dijkstra F; Kislaya I; Gherasim A; McDonald SA; Kissling E; Valenciano M; Meijer A; Hooiveld M; Nunes B; Larrauri A
    Euro Surveill; 2019 Nov; 24(45):. PubMed ID: 31718740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Public health and economic benefits of seasonal influenza vaccination in risk groups in France, Italy, Spain and the UK: state of play and perspectives.
    de Fougerolles TR; Baïssas T; Perquier G; Vitoux O; Crépey P; Bartelt-Hofer J; Bricout H; Petitjean A
    BMC Public Health; 2024 May; 24(1):1222. PubMed ID: 38702667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-Effectiveness of Pediatric Influenza Vaccination in The Netherlands.
    de Boer PT; Nagy L; Dolk FCK; Wilschut JC; Pitman R; Postma MJ
    Value Health; 2021 Jan; 24(1):19-31. PubMed ID: 33431149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maternal influenza vaccine strategies in Kenya: Which approach would have the greatest impact on disease burden in pregnant women and young infants?
    McMorrow ML; Emukule GO; Obor D; Nyawanda B; Otieno NA; Makokha C; Mott JA; Bresee JS; Reed C
    PLoS One; 2017; 12(12):e0189623. PubMed ID: 29283997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of Strategies for Offering Influenza Vaccine in the Pediatric Emergency Department.
    Hart RJ; Stevenson MD; Smith MJ; LaJoie AS; Cross K
    JAMA Pediatr; 2018 Jan; 172(1):e173879. PubMed ID: 29114729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.